International Union of Angiology Congress. , 1995/04.
Conservative treatment of venous disease is difficult.
There is much skepticism concerning the efficacy of drugs in venous diseases.
Nevertheless, in Germany, these drugs have obtained a substantial market share with a tendency to increase.
The objective of this empirical study is to evaluate the socioeconomic characteristics of consumers of venous medications and to explore the demand elasticity with respect to health insurance coverage.
In a first set of inquiries 12,500 households were asked from July to September 1993 if they had purchased prescribed venous medication during the past 12 months.
About 10,000 households with 19,750 persons aged fifteen years and older responded ; 2,080 (11%) of those persons had consumed prescribed medications against venous disease over the past twelve months.
In the second part of the study a detailed questionnaire was sent to the 2,080 purchasers and to 3,000 randomly selected nonpurchasers ; 1,930 (92.8%) purchasers and 2,291 (76.4%) nonpurchasers returned their questionnaire.
The key findings can be summarized as follows : The percentage of women is much higher in the group of purchasers (80%) than in the group of nonpurchasers.
Most of the purchasers are over fifty years old.
Only one quarter of the purchasers are under fifty.
One third of the purchasers are retired, and only 29% are working.
In the group of nonpurchasers 56% are working and only 17% are retired. (...)
Mots-clés Pascal : Insuffisance veineuse, Chimiothérapie, Veinotrope, Traitement, Consommateur, Utilisateur, Epidémiologie, Statut socioéconomique, Questionnaire, Allemagne, Europe, Homme, Appareil circulatoire pathologie, Vaisseau sanguin pathologie, Veine pathologie
Mots-clés Pascal anglais : Venous incompetence, Chemotherapy, Venotropic agent, Treatment, Consumer, User, Epidemiology, Socioeconomic status, Questionnaire, Germany, Europe, Human, Cardiovascular disease, Vascular disease, Venous disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0395381
Code Inist : 002B02F07. Création : 12/09/1997.